Preliminary observations on the effects of acute infusion of growth hormone on coronary vasculature and on myocardial function and energetics of an isolated and blood-perfused heart

Journal of Endocrinological Investigation

Volumn 26, Issue 1, 2003, Pages

  Lorusso, Roberto ^a   Pasini, E ^b   Cargnoni, A ^b   Ceconi, C ^b   Volterrani, M ^b   Burattin, A ^d   Valle, D ^c   Ferrari, R ^b   Giustina, A ^d  

^a Ospedale Civile   (Italy)

^b IRCCS   (Italy)

^c Eli Lilly Italia   (Italy)

^d UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Coronary resistance; Growth hormone; Isolated blood perfused heart; Myocardial ischemia reperfusion damage

Indexed keywords

CREATINE KINASE; FATTY ACID; GROWTH HORMONE; LACTIC ACID; PROTEIN;

ACUTE DRUG ADMINISTRATION; AEROBIC METABOLISM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD DONOR; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DILATATION; CORONARY BLOOD VESSEL; CREATINE KINASE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; DRUG EFFECT; DRUG INFUSION; DRUG MONITORING; ENERGY TRANSFER; ENZYME RELEASE; EXPERIMENTAL MODEL; GENE EXPRESSION; HEART FUNCTION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART MUSCLE REPERFUSION; HEART PERFUSION; HEMOPERFUSION; HIGH ENERGY PHOSPHATE; INTRACORONARY INFUSION; ISOLATED HEART; LACTATE BLOOD LEVEL; LIPID TRANSPORT; MALE; METABOLIC PARAMETERS; NONHUMAN; PROTEIN SYNTHESIS; RABBIT; REPERFUSION INJURY; STUNNED HEART MUSCLE; VASODILATATION;

EID: 0037217174     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03345113     Document Type: Article

References (18)

1. Volterrani M., Manelli F., Cicoira M., Lorusso R., Giustina A. Role of growth hormone in chronic heart failure. Drugs 2000, 60: 711-719.
2. Yang R., Bunting S., Gillet N., Clark R., Hongkui J. Growth hormone improves cardiac performance in experimental heart failure. Circulation 1995, 92: 262-267.
3. Rossoni G., De Gennaro M., Colonna V. et al. Protective activity of hexarelin or growth hormone against postischemic ventricular dysfunction in hearts from aged rats. J. Cardiovasc. Pharmacol. 1998, 32: 260-265.
4. Giustina A., Lorusso R., Borghetti V., Bugari G., Misitano V., Alfieri O. Impaired spontaneous growth hormone secretion in severe dilated cardiomyopathy. Am. Heart J. 1996, 131: 620-622.
5. Pasini E., Solfrini R., Bachetti T. et al. The blood perfused isolated heart: Characterization of the model. Basic Res. Cardiol. 1999, 94: 215-222.
6. Volteranni M., Desenzani P., Lorusso R., D'Aloia A., Manelli F., Giustina A. Haemodynamic effects of intravenous growth hormone in congestive heart failure. Lancet 1997, 349: 1067-1068.
7. Fazio S., Sabatini D., Capaldo B. et al. A preliminary study of growth hormone in the treatment of dilated cardiomyopathy. N. Engl. J. Med. 1999, 334: 809-814.
8. Manelli F., Volterrani M., Lorusso R., Romanelli G., Giustina A. Acute growth hormone effects in human subjects with heart failure. In: Giustina A. (Ed.), Growth Hormone and the Heart. Kluwer Academic Publisher, 2000, 87-96.
9. Houck W.V., Pan L.C., Kribbs S.B. et al. Effects of growth hormone supplementation on left ventricular morphology and myocyte function with the development of congestive heart failure. Circulation 1999, 100: 2003-2009.
10. Kinugawa S., Tsutsui H., Ide T. et al. Positive inotropic effect of insulin-like growth factor-I on normal and failing cardiac myocytes. Cardiovasc. Res. 1999, 43: 157-164.
11. Broglio F., Benso A., Valetto M.R. et al. Growth hormone-independent cardiotropic activities of growth hormone-releasing peptides in normal subjects, in patients with growth hormone deficiency, and in patients with idiopathic or ischemic dilated cardiomyopathy. Endocrine 2001, 14: 105-108.
12. Giustina A., Volterrani M., Manelli F. et al. Endocrine predictors of acute hemodynamic effects of growth hormone in congestive heart failure. Am. Heart J. 1999, 137: 1035-1043.
13. Anker S., Volterrani M., Pflaum C.D. et al. Acquired growth hormone resistance in patients with chronic heart failure: Implications for therapy with growth hormone. J. Am. Coll. Cardiol. 2001, 443-452.
14. Giustina A., Veldhuis J. Pathophysiology of the neuroregulations of growth hormone secretion in experimental and the human. Endocr. Rev. 1998, 19: 717-797.
15. Capaldo B., Guardasole V., Pardo F. et al. Abnormal vascular reactivity in growth hormone deficiency. Circulation 2001, 103: 520-524.
16. Grimm D., Cameron D., Griese P.G., Riegger G.A.J., Kromer E.P. Differential effects of growth hormone on cardiomyocyte and extracellular matrix protein remodeling following experimental myocardial infarction. Cardiovasc. Res. 1998, 40: 297-306.
17. Isgaard J., Bergh C.H., Caidahl K., Lomsky M., Hjalmarson A., Bengtsson B.A. A placebo-controlled study of growth hormone in patients with congestive heart failure. Eur. Heart J. 1998, 19: 1704-1711.
18. Osterziel K.J., Strohm O., Schuler J. et al. Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy. Lancet 1998, 351: 1233-1237.